ID   SK-LC-2
AC   CVCL_5468
SY   SK LC 02; SK-LC2
DR   Cosmic; 1089233
DR   IARC_TP53; 18799
DR   Wikidata; Q54953709
RX   PubMed=2540905;
RX   PubMed=2784858;
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
RX   PubMed=9636188;
RX   PubMed=12794755;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro85fs (c.253delC); Zygosity=Unspecified (PubMed=12794755).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
RX   PubMed=2540905;
RA   Takahashi T., Obata Y., Sekido Y., Hida T., Ueda R., Watanabe H.,
RA   Ariyoshi Y., Sugiura T., Takahashi T.;
RT   "Expression and amplification of myc gene family in small cell lung
RT   cancer and its relation to biological characteristics.";
RL   Cancer Res. 49:2683-2688(1989).
//
RX   PubMed=2784858; DOI=10.1073/pnas.86.8.2804; PMCID=PMC287007;
RA   Knuth A., Wolfel T., Klehmann-Hieb E., Boon T.,
RA   Meyer zum Buschenfelde K.-H.;
RT   "Cytolytic T-cell clones against an autologous human melanoma:
RT   specificity study and definition of three antigens by
RT   immunoselection.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:2804-2808(1989).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=6208122; DOI=10.1089/hyb.1.1982.1.139;
RA   Anger B.R., Lloyd K.O., Oettgen H.F., Old L.J.;
RT   "Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3
RT   with specificity for H(O) blood group antigen.";
RL   Hybridoma 1:139-147(1982).
//
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720;
RA   Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.;
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
//
RX   PubMed=9636188; DOI=10.1073/pnas.95.13.7556; PMCID=PMC22681;
RA   Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M.,
RA   Old L.J., Schreiber R.D.;
RT   "Demonstration of an interferon gamma-dependent tumor surveillance
RT   system in immunocompetent mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:7556-7561(1998).
//
RX   PubMed=12794755; DOI=10.1002/ijc.11184;
RA   Endoh H., Yatabe Y., Shimizu S., Tajima K., Kuwano H., Takahashi T.,
RA   Mitsudomi T.;
RT   "RASSF1A gene inactivation in non-small cell lung cancer and its
RT   clinical implication.";
RL   Int. J. Cancer 106:45-51(2003).
//